Procaps Group SA - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
PROC Nasdaq 2834 https://www.procapsgroup.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Procaps Group SA

Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024 - Nov 22nd, 2023 1:30 pm
Procaps Group Update on Third Quarter Results - Nov 14th, 2023 10:25 pm
Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023 - Nov 10th, 2023 4:37 pm
Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia - Oct 30th, 2023 12:30 pm
Procaps Appoints Sandra Sánchez y Oldenhage to Board of Directors - Oct 23rd, 2023 9:01 pm
Procaps Group to Participate at CPHI Barcelona 2023 - Oct 16th, 2023 12:31 pm
Procaps Group to Host Webinar on Colombian Pharma Market - Oct 2nd, 2023 12:00 pm
Procaps Group to Participate at BTG 2023 LatAm CEO Conference and Roth 2023 Healthcare Opportunities Conference in October - Sep 15th, 2023 12:20 pm
Procaps Group Announces the Expansion of its Oncology Portfolio - Sep 7th, 2023 12:30 pm
Procaps Group Reports Second Quarter 2023 Results - Sep 5th, 2023 12:25 pm
Procaps Group to Report Second Quarter and First Half 2023 Results and Host Conference Call on Tuesday - Aug 31st, 2023 10:35 pm
Procaps Group Publishes White Paper on Innovative Gummy Technology - Aug 16th, 2023 12:31 pm
Procaps Group Reports First Quarter 2023 Results - Jun 5th, 2023 11:45 pm
Procaps Group Reports Fourth Quarter and Full Year 2022 Results - May 12th, 2023 9:30 pm
Financial Results and Business Update Conference Call to be Held May 2023 in Conjunction with 20-F Filing - May 1st, 2023 12:17 pm
Procaps Issues Shareholder Letter and Provides Preliminary Fiscal Year 2022 Financial Results and 2023 Guidance - Feb 13th, 2023 9:36 pm
Procaps Announces Key Changes to the Board of Directors - Jan 19th, 2023 9:32 pm
Procaps Group Announces Termination of Acquisition Agreement with Grupo Somar - Jan 3rd, 2023 9:13 pm
Procaps to Present at 2023 Annual J.P. Morgan Healthcare Conference - Dec 29th, 2022 1:00 pm
Update on Proposed Acquisition of Grupo Somar - Dec 22nd, 2022 9:02 pm